Lipid Disorder Treatment

Lipid Disorder Treatment

Global Lipid Disorder Treatment Market to Reach $44.4 Billion by 2030
The global market for Lipid Disorder Treatment estimated at US$29.2 Billion in the year 2023, is expected to reach US$44.4 Billion by 2030, growing at a CAGR of 6.2% over the period 2023-2030.

The U.S. Market is Estimated at $7.7 Billion, While China is Forecast to Grow at 9.2% CAGR
The Lipid Disorder Treatment market in the U.S. is estimated at US$7.7 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$10.3 Billion by the year 2030 trailing a CAGR of 9.2% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 5.7% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 42 Featured) -
  • AstraZeneca PLC
  • Emcure Pharmaceuticals Private Limited
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Lipid Disorder Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
Global Economic Update
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Lipid Disorder Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Lipid Disorder Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 4: World Lipid Disorder Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Lipid Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 5: USA Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 6: USA Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
CANADA
TABLE 7: Canada Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 8: Canada Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
JAPAN
Lipid Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 9: Japan Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 10: Japan Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
CHINA
Lipid Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 11: China Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 12: China Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
EUROPE
Lipid Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 13: Europe Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 14: Europe Historic Review for Lipid Disorder Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 15: Europe 16-Year Perspective for Lipid Disorder Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
FRANCE
Lipid Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 16: France Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 17: France Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
GERMANY
Lipid Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 18: Germany Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 19: Germany Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
ITALY
TABLE 20: Italy Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 21: Italy Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
UNITED KINGDOM
Lipid Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 22: UK Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 23: UK Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
SPAIN
TABLE 24: Spain Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 25: Spain Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
RUSSIA
TABLE 26: Russia Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 27: Russia Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
REST OF EUROPE
TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 29: Rest of Europe Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
ASIA-PACIFIC
Lipid Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 31: Asia-Pacific Historic Review for Lipid Disorder Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 32: Asia-Pacific 16-Year Perspective for Lipid Disorder Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
AUSTRALIA
Lipid Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 33: Australia Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 34: Australia Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
INDIA
Lipid Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 35: India Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: India Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
SOUTH KOREA
TABLE 37: South Korea Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 38: South Korea Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
REST OF ASIA-PACIFIC
TABLE 39: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 40: Rest of Asia-Pacific Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
LATIN AMERICA
Lipid Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 41: Latin America Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 42: Latin America Historic Review for Lipid Disorder Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: Latin America 16-Year Perspective for Lipid Disorder Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
ARGENTINA
TABLE 44: Argentina Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Argentina Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
BRAZIL
TABLE 46: Brazil Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 47: Brazil Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
MEXICO
TABLE 48: Mexico Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 49: Mexico Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
REST OF LATIN AMERICA
TABLE 50: Rest of Latin America Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Rest of Latin America Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
MIDDLE EAST
Lipid Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 52: Middle East Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 53: Middle East Historic Review for Lipid Disorder Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 54: Middle East 16-Year Perspective for Lipid Disorder Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
IRAN
TABLE 55: Iran Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 56: Iran Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
ISRAEL
TABLE 57: Israel Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 58: Israel Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
SAUDI ARABIA
TABLE 59: Saudi Arabia Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: Saudi Arabia Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
UNITED ARAB EMIRATES
TABLE 61: UAE Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 62: UAE Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
REST OF MIDDLE EAST
TABLE 63: Rest of Middle East Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 64: Rest of Middle East Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
AFRICA
Lipid Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 65: Africa Recent Past, Current & Future Analysis for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: Africa Historic Review for Lipid Disorder Treatment by Segment - Lipid Disorder Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings